Molecular Genetics Thalassaemia Grants Obtained

Home › Departments & Clinics › Molecular Genetics Thalassaemia › Grants Obtained

Grants:

 

 

  1. HU-Pharmgk 2007-2009.  Funded by RPF with the amount of 79,200 CYP.  Pharmacogenomic analysis of β-thalassaemia patients under Hydroxyurea treatment: Implications for β-thalassaemia therapeutics.
  2. MedGenNet, 2007-2009.  Funded by FP6 with the amount of 749,177 EURO.  Euro-Mediterranean Network for Genetic Services.
  3.  (ITHANET), 2006-2008.  Funded by FP6 with the total amount of 1,200,000 EURO.  elnfrastructure for Thalassaemia Research Network.
  4. ΕΕAΘΑ, 2005-2008.  Funded by the RPF with the total amount of CYP 57,475,  Reactivation of HbF for thalassaemia treatment.
  5.  (ENERCA II) 2005-2007.  Funded by EC with the total amount of 658,000 EURO.  European Network for Rare and Congenital Anaemias.
  6.  (SAFE) 2004-2008.  Funded by EC with the total amount of 13.000.000 EURO.  Special Non-Invasive Advances in Foetal and Neonatal Evaluation Network.
  7.  (EUMEDIS) 2002-2005.  Funded by E.C. with the total amount of 1.040.000 EURO.
  8. Phenotype/Genotype correlation in thalassaemia intermedia.  Dec. 1998 - Dec. 2001.  Funded by the International Atomic Energy Agency (IAEA) with the amount of US$16,000.
  9. Euro-Mediterranean Network for Genetic services. 
  10. Determination of unknown α-thal mutations in Cyprus.  Oct 1998 - April 2001.  Funded by the Pancyprian Antianemic Association with the amount of CYP 8,900.
  11. Prevention of Scrapie in Cyprus.  PrP Genotyping.  June 1998 - Dec. 2000.  Funded by EU grant of the Veterinary Services with the amount of CYP 40,000.
  12. Diagnosis of genetic disorders using radionuclide-based molecular methods.  Renewal April 1998 - Feb 1999.  Funded by the International Atomic Energy Agency (IAEA) with the amount of US$ 5,000. 
  13. Prevention of Scrapie in Cyprus.  PrP Genotyping.  June 1997 - Dec 1997.  Funded by  the Veterinary Services with the amount of CYP 5,800.